Improving biomanufacturing through synthetic promoters tailored to specific producer cell lines, viral vector and recombinant proteins

Sarah Haecker Meeks

Sarah Haecker Meeks, PhD
Vice President, Business Development

  • Enable industrial scale-up of biologics and viral vectors
  • Fine tune expression of components
  • Silence gene expression during production
  • Reduced COGS
  • Comprehensive technology applications including AAV, Lentivirus, Retrovirus, Monoclonal Antibodies and Recombinant Proteins